BrightSpring Health Services Inc has a consensus price target of $15.94, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, HSBC, and Goldman Sachs on May 6, 2024, March 6, 2024, and March 4, 2024. With an average price target of $17.33 between Wells Fargo, HSBC, and Goldman Sachs, there's an implied 52.18% upside for BrightSpring Health Services Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/06/2024 | Buy Now | 40.47% | Wells Fargo | Stephen Baxter | $15 → $16 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | 14.14% | HSBC | Sidharth Sahoo | → $13 | Initiates | → Buy | Get Alert |
03/04/2024 | Buy Now | 101.93% | Goldman Sachs | Jamie Perse | $26 → $23 | Maintains | Buy | Get Alert |
02/20/2024 | Buy Now | 0.97% | Deutsche Bank | Pito Chickering | → $11.5 | Initiates | → Hold | Get Alert |
02/20/2024 | Buy Now | 31.69% | Leerink Partners | Whit Mayo | → $15 | Initiates | → Outperform | Get Alert |
02/20/2024 | Buy Now | 22.91% | B of A Securities | Joanna Gajuk | → $14 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 31.69% | UBS | A.J. Rice | → $15 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 31.69% | Wells Fargo | Stephen Baxter | → $15 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 58.03% | Jefferies | Brian Tanquilut | → $18 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | 58.03% | Morgan Stanley | Erin Wright | → $18 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 128.27% | Goldman Sachs | Jamie Perse | → $26 | Initiates | → Buy | Get Alert |
The latest price target for BrightSpring Health (NASDAQ: BTSG) was reported by Wells Fargo on May 6, 2024. The analyst firm set a price target for $16.00 expecting BTSG to rise to within 12 months (a possible 37.58% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ: BTSG) was provided by Wells Fargo, and BrightSpring Health maintained their overweight rating.
There is no last upgrade for BrightSpring Health.
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $15.00 to $16.00. The current price BrightSpring Health (BTSG) is trading at is $11.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.